Histopathological Variability and Concomitant Lesions in Pterygium in a Large Case Series.

J Ophthalmol

The MUHC-McGill University Ocular Pathology & Translational Research Laboratory, McGill University, Montreal, Quebec, Canada.

Published: March 2021

Pterygium is a common lesion consisting of fleshy conjunctival growth extending towards the cornea. There is no documented risk of malignant transformation; however, concomitant disease is not rare, and its link to sunlight exposure indicates a risk of other malignancies. The purpose of our study is to describe histopathological features of resected pterygiums and to recognize patients at risk of other conjunctival diseases. One hundred and forty-nine formalin-fixed and paraffin-embedded pterygium samples were subjected to histopathological analysis. Histological H&E sections were obtained and digitalized using a Zeiss Axio Scan.Z1 slide scanner. Thirteen predefined morphological features were used to record histopathological changes in the epithelium and substantia propria. Neovascularization was observed in 54% of the samples. Sun damage, comprising solar elastosis and stromal plaque, was present in 81% of the samples. Variation in epithelial thickness was the most common change, with acanthosis and atrophy being observed in 62% and 26% of the samples, respectively. In our series, 21% (31/149) of pterygiums showed mild to moderate dysplasia, a finding that may be associated to ocular surface squamous neoplasia (OSSN). Moreover, 32% (47/149) of the cases showed melanocytic hyperplasia, which could represent primary acquired melanosis (PAM). There is a positive correlation between dysplasia and chronic inflammation (=0.012) and an inverse correlation with epithelial atrophy (=0.001) and neovascularization (=0.05). Similarly, a positive correlation is observed between goblet cell hyperplasia and melanocytic hyperplasia (=0.02). Our findings show that pterygiums harbour histological features that may be suggestive of OSSN or PAM in 53% of our patients. Whilst being on the benign side of the spectrum, these two entities are known for their potential progression to malignancy. A recommendation is made for all surgically excised pterygiums to be sent for histopathological diagnosis, and clear guidelines for reporting of these lesions should be established. Associated histopathological findings suggestive of other concomitant diseases should be identified to insure adequate follow-up of these patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004360PMC
http://dx.doi.org/10.1155/2021/6623794DOI Listing

Publication Analysis

Top Keywords

melanocytic hyperplasia
8
positive correlation
8
histopathological
6
histopathological variability
4
variability concomitant
4
concomitant lesions
4
lesions pterygium
4
pterygium large
4
large case
4
case series
4

Similar Publications

[Significance of the preferentially expressed antigen in melanoma in discriminating the conjunctival malignant melanoma and pigmented nevus].

Zhonghua Yan Ke Za Zhi

November 2024

Zhongshan Ophthalmic Center, Sun Yat-sen University, State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.

Article Synopsis
  • - The study examined the role of preferentially expressed antigen in melanoma (PRAME) for distinguishing between conjunctival malignant melanoma and pigmented nevus using samples from 172 patients collected from 2017 to 2024.
  • - Results showed that 89.53% of malignant melanoma cases tested positive for PRAME, compared to only 1.16% in pigmented nevus cases, indicating a significant difference (p<0.05).
  • - PRAME demonstrated high sensitivity (89.53%) and specificity (98.84%) as a diagnostic biomarker for conjunctival malignant melanoma, although expression did not vary significantly across different clinical stages of the disease.
View Article and Find Full Text PDF

S100 protein expression in PKC-fused blue naevi, cellular blue naevi and PRKAR1A-inactivated pigmented epithelioid melanocytomas.

Pathology

February 2025

Department de Biopathologie, Centre Léon Bérard, Lyon, France; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France. Electronic address:

Recent data have redefined the genetic spectrum of pigmented epithelioid melanocytomas (PEMs). PEM is now defined by a secondary genetic event, a protein kinase cAMP-dependent type I regulatory subunit alpha (PRKAR1A) inactivation, that confers the specific cytomorphology of the entity, but this event can arise within a naevus with a genetic background of common, blue or Spitz type. PKC-fused melanocytic proliferations, although they can exhibit PEM-like morphological features, have now been regrouped within the blue group of tumours.

View Article and Find Full Text PDF

SF method for removing small skin melanocytic nevus.

Front Surg

August 2024

Department of Burns and Plastic Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.

Article Synopsis
  • A melanocytic nevus is a common type of skin growth that can look bad and might turn into cancer.
  • Researchers wanted to find the best way to remove these tiny skin spots, using a method called SF.
  • The study found that the SF method worked really well, was quicker, had no problems afterwards, and made all the patients happy with the results!*
View Article and Find Full Text PDF

Background: Preferentially expressed antigen in melanoma (PRAME) has been extensively studied in cutaneous melanocytic tumors and has proven valuable as a diagnostic adjunct in routine dermatopathology practice. However, its expression in cutaneous vascular neoplasms, particularly angiosarcomas (AS), remains largely unexplored.

Methods: To further explore PRAME expression in cutaneous AS, 18 cases of post-irradiation and 13 cases of primary cutaneous AS were evaluated for PRAME.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!